Robert L. Young, M.D.; Lionel E. Harkleroad, B.S.C.; John G. Weg, M.D., F.A.C.P.; Robert E. Lordon, M.D.
This content is PDF only. Please click on the PDF icon to access.
Steroid therapy has long been advocated for treatment of pulmonary dysfunction in sarcoidosis. Current medical literature, however, reveals no controlled prospective study which establishes the efficacy of such therapy. Four years ago a prospective study using alternate case treatment with steroids was initiated in patients with pulmonary function abnormalities due to sarcoidosis. Patients with normal pulmonary function were not included in the study. There were 13 patients in the treated group and 12 in the control group. The two groups were similar in sex, age, race, degree of pulmonary dysfunction, and duration of disease. Over 80% of patients in both
Young RL, Harkleroad LE, Weg JG, Lordon RE. A Prospective Study of Glucocorticoid Therapy in Pulmonary Sarcoidosis.. Ann Intern Med. ;72:809. doi: 10.7326/0003-4819-72-5-809_2
Download citation file:
© 2019
Published: Ann Intern Med. 1970;72(5):809.
DOI: 10.7326/0003-4819-72-5-809_2